Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.
Barbosa BJAP, Resende EPF, Castilhos RM, Borelli WV, Frota NAF, Balthazar MLF, Amato ACS, Smid J, Barbosa MT, Coutinho AM, de Souza LC, Schilling LP, da Silva MNM, Fernandes GBP, Bertolucci PHF, Nitrini R, Engelhardt E, Forlenza OV, Caramelli P, Brucki SMD, Studart A. Barbosa BJAP, et al. Among authors: forlenza ov. Dement Neuropsychol. 2024 Nov 11;18:e2024C002. doi: 10.1590/1980-5764-DN-2024-C002. eCollection 2024. Dement Neuropsychol. 2024. PMID: 39534440 Free PMC article.
[Treatment of Alzheimer's disease: recommendations and suggestions of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology].
Engelhardt E, Brucki SM, Cavalcanti JL, Forlenza OV, Laks J, Vale FA; Departamento de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Engelhardt E, et al. Among authors: forlenza ov. Arq Neuropsiquiatr. 2005 Dec;63(4):1104-12. doi: 10.1590/s0004-282x2005000600035. Epub 2005 Dec 15. Arq Neuropsiquiatr. 2005. PMID: 16400437 Free article. Portuguese.
Neuropsychiatric symptoms in the prodromal stages of dementia.
Stella F, Radanovic M, Balthazar ML, Canineu PR, de Souza LC, Forlenza OV. Stella F, et al. Among authors: forlenza ov. Curr Opin Psychiatry. 2014 May;27(3):230-5. doi: 10.1097/YCO.0000000000000050. Curr Opin Psychiatry. 2014. PMID: 24613979 Review.
Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study).
Caramelli P, Laks J, Palmini AL, Nitrini R, Chaves ML, Forlenza OV, Vale Fde A, Barbosa MT, Bottino CM, Machado JC, Charchat-Fichman H, Lawson FL. Caramelli P, et al. Among authors: forlenza ov. Arq Neuropsiquiatr. 2014 Jun;72(6):411-7. doi: 10.1590/0004-282x20140055. Arq Neuropsiquiatr. 2014. PMID: 24964105 Free article. Clinical Trial.
Criteria for the diagnosis of Alzheimer's disease: Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.
Frota NAF, Nitrini R, Damasceno BP, Forlenza OV, Dias-Tosta E, da Silva AB, Herrera Junior E, Magaldi RM; Group Recommendations in Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology. Frota NAF, et al. Among authors: forlenza ov. Dement Neuropsychol. 2011 Jul-Sep;5(3):146-152. doi: 10.1590/S1980-57642011DN05030002. Dement Neuropsychol. 2011. PMID: 29213739 Free PMC article. Review.
Cognitive Reserve Relates to Functional Network Efficiency in Alzheimer's Disease.
Weiler M, Casseb RF, de Campos BM, de Ligo Teixeira CV, Carletti-Cassani AFMK, Vicentini JE, Magalhães TNC, de Almeira DQ, Talib LL, Forlenza OV, Balthazar MLF, Castellano G. Weiler M, et al. Among authors: forlenza ov. Front Aging Neurosci. 2018 Aug 21;10:255. doi: 10.3389/fnagi.2018.00255. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30186154 Free PMC article.
Topography of 11C-Pittsburgh compound B uptake in Alzheimer's disease: a voxel-based investigation of cortical and white matter regions.
Faria DP, Duran FL, Squarzoni P, Coutinho AM, Garcez AT, Santos PP, Brucki SM, de Oliveira MO, Trés ES, Forlenza OV, Nitrini R, Buchpiguel CA, Busatto Filho G. Faria DP, et al. Among authors: forlenza ov. Braz J Psychiatry. 2019 Mar-Apr;41(2):101-111. doi: 10.1590/1516-4446-2017-0002. Epub 2018 Dec 6. Braz J Psychiatry. 2019. PMID: 30540022 Free PMC article.
Passive antiamyloid immunotherapy for Alzheimer's disease.
Loureiro JC, Pais MV, Stella F, Radanovic M, Teixeira AL, Forlenza OV, de Souza LC. Loureiro JC, et al. Among authors: forlenza ov. Curr Opin Psychiatry. 2020 May;33(3):284-291. doi: 10.1097/YCO.0000000000000587. Curr Opin Psychiatry. 2020. PMID: 32040044 Review.
Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.
Coutinho AM, Busatto GF, de Gobbi Porto FH, de Paula Faria D, Ono CR, Garcez AT, Squarzoni P, de Souza Duran FL, de Oliveira MO, Tres ES, Brucki SMD, Forlenza OV, Nitrini R, Buchpiguel CA. Coutinho AM, et al. Among authors: forlenza ov. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2666-2680. doi: 10.1007/s00259-020-04714-0. Epub 2020 Feb 13. Eur J Nucl Med Mol Imaging. 2020. PMID: 32055966
236 results